ALBERTO A JIMENEZ MD
Prescription History 1285795708
General Practice in East Chicago, IN
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for ALBERTO A JIMENEZ MD, an active General Practice specialist practicing in East Chicago, IN. Our medical registry currently tracks 2 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 23 documented patient claims. Among these therapy options, the most frequently utilized medication is Victoza 2-Pak, which accounts for 12 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Claims | 30-Day Fills | Days Supply | Cost / Claim | Utilization vs IN Avg |
|---|---|---|---|---|---|
| Victoza 2-PakLiraglutide | 12 | 12.0 | 354 | $797.16▼ below IN avg | ▼ Below Avg. |
Utilization: claims vs the average IN prescriber Averages are among IN prescribers of this medication. Utilization reflects practice size as well as clinical preference. Cost per claim: this provider vs the IN average This provider's average cost per claim is below the IN average for this medication. 12.0 30-Day Fills 354 Days Supply About Victoza 2-Pak: This medication is used with a doctor-approved exercise, behavior change, and reduced-calorie diet program to help you lose weight. Show more ▾ It is used by certain overweight people, such as those who are obese or have weight-related medical problems. Losing weight and keeping it off can lessen the many health risks that come with obesity, including heart disease, diabetes, high blood pressure, and a shorter life. Liraglutide is similar to a natural hormone in your body (incretin). It works by controlling your appetite. An analog of GLUCAGON-LIKE PEPTIDE 1 and agonist of the GLUCAGON-LIKE PEPTIDE 1 RECEPTOR that is used as a HYPOGLYCEMIC AGENT and supplemental therapy in the treatment of DIABETES MELLITUS by patients who do not respond to METFORMIN. | |||||
| GlyxambiEmpagliflozin/Linagliptin | 11 | 11.0 | 330 | $635.33▼ below IN avg | ▼ Below Avg. |
Utilization: claims vs the average IN prescriber Averages are among IN prescribers of this medication. Utilization reflects practice size as well as clinical preference. Cost per claim: this provider vs the IN average This provider's average cost per claim is below the IN average for this medication. 11.0 30-Day Fills 330 Days Supply About Glyxambi: This medication is a combination of 2 drugs: empagliflozin and linagliptin. Show more ▾ It is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Empagliflozin works by increasing the removal of sugar by your kidneys. Linagliptin works by increasing levels of natural substances called incretins. Incretins help to control blood sugar by increasing insulin release, especially after a meal. They also decrease the amount of sugar your liver makes. | |||||
About this data. The prescription history for ALBERTO A JIMENEZ MD is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall General Practice prescribing approach at this East Chicago, IN practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among IN prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.
